Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys.

Yang JJ, Kularatne SA, Chen X, Low PS, Wang E.

Mol Pharm. 2012 Feb 6;9(2):310-7. doi: 10.1021/mp200483t. Epub 2012 Jan 9.

PMID:
22171616
[PubMed - indexed for MEDLINE]
2.

Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging.

Yang J, Chen H, Vlahov IR, Cheng JX, Low PS.

Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13872-7. Epub 2006 Sep 1.

PMID:
16950881
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Synthesis and biological evaluation of a folate-targeted rhaponticin conjugate.

Liang X, Sun Y, Zeng W, Liu L, Ma X, Zhao Y, Fan J.

Bioorg Med Chem. 2013 Jan 1;21(1):178-85. doi: 10.1016/j.bmc.2012.10.044. Epub 2012 Nov 3.

PMID:
23177726
[PubMed - indexed for MEDLINE]
4.

Regioselective synthesis of folate receptor-targeted agents derived from epothilone analogs and folic acid.

Vlahov IR, Vite GD, Kleindl PJ, Wang Y, Santhapuram HK, You F, Howard SJ, Kim SH, Lee FF, Leamon CP.

Bioorg Med Chem Lett. 2010 Aug 1;20(15):4578-81. doi: 10.1016/j.bmcl.2010.06.016. Epub 2010 Jun 8.

PMID:
20594844
[PubMed - indexed for MEDLINE]
5.

Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.

Shukla S, Wu G, Chatterjee M, Yang W, Sekido M, Diop LA, Müller R, Sudimack JJ, Lee RJ, Barth RF, Tjarks W.

Bioconjug Chem. 2003 Jan-Feb;14(1):158-67.

PMID:
12526705
[PubMed - indexed for MEDLINE]
6.

Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy.

Sandoval RM, Kennedy MD, Low PS, Molitoris BA.

Am J Physiol Cell Physiol. 2004 Aug;287(2):C517-26. Epub 2004 Apr 21.

PMID:
15102609
[PubMed - indexed for MEDLINE]
Free Article
7.

In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy.

Garcia-Bennett A, Nees M, Fadeel B.

Biochem Pharmacol. 2011 Apr 15;81(8):976-84. doi: 10.1016/j.bcp.2011.01.023. Epub 2011 Feb 12.

PMID:
21300030
[PubMed - indexed for MEDLINE]
8.

Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo.

Müller C, Brühlmeier M, Schubiger PA, Schibli R.

J Nucl Med. 2006 Dec;47(12):2057-64.

PMID:
17138750
[PubMed - indexed for MEDLINE]
Free Article
9.

Synthesis and biological evaluation of EC72: a new folate-targeted chemotherapeutic.

Leamon CP, Reddy JA, Vlahov IR, Vetzel M, Parker N, Nicoson JS, Xu LC, Westrick E.

Bioconjug Chem. 2005 Jul-Aug;16(4):803-11.

PMID:
16029021
[PubMed - indexed for MEDLINE]
10.

Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors.

Vlashi E, Sturgis JE, Thomas M, Low PS.

Mol Pharm. 2009 Nov-Dec;6(6):1868-75. doi: 10.1021/mp900158d.

PMID:
19754150
[PubMed - indexed for MEDLINE]
11.
12.

Synthesis and in vitro/in vivo evaluation of 99mTc-labeled folate conjugates for folate receptor imaging.

Lu J, Pang Y, Xie F, Guo H, Li Y, Yang Z, Wang X.

Nucl Med Biol. 2011 May;38(4):557-65. doi: 10.1016/j.nucmedbio.2010.11.007. Epub 2011 Feb 4.

PMID:
21531293
[PubMed - indexed for MEDLINE]
13.

Folic acid modified cationic γ-cyclodextrin-oligoethylenimine star polymer with bioreducible disulfide linker for efficient targeted gene delivery.

Zhao F, Yin H, Zhang Z, Li J.

Biomacromolecules. 2013 Feb 11;14(2):476-84. doi: 10.1021/bm301718f. Epub 2013 Jan 16.

PMID:
23323627
[PubMed - indexed for MEDLINE]
14.

Tumor targeting using 67Ga-DOTA-Bz-folate--investigations of methods to improve the tissue distribution of radiofolates.

Müller C, Vlahov IR, Santhapuram HK, Leamon CP, Schibli R.

Nucl Med Biol. 2011 Jul;38(5):715-23. doi: 10.1016/j.nucmedbio.2010.12.013. Epub 2011 Mar 3.

PMID:
21718947
[PubMed - indexed for MEDLINE]
15.

Targeting folate receptors to treat invasive urinary bladder cancer.

Dhawan D, Ramos-Vara JA, Naughton JF, Cheng L, Low PS, Rothenbuhler R, Leamon CP, Parker N, Klein PJ, Vlahov IR, Reddy JA, Koch M, Murphy L, Fourez LM, Stewart JC, Knapp DW.

Cancer Res. 2013 Jan 15;73(2):875-84. doi: 10.1158/0008-5472.CAN-12-2101. Epub 2012 Nov 29.

PMID:
23204225
[PubMed - indexed for MEDLINE]
Free Article
16.

Synthesis and evaluation of a novel lipophilic folate receptor targeting ligand.

Liu Y, Xu S, Teng L, Yung B, Zhu J, Ding H, Lee RJ.

Anticancer Res. 2011 May;31(5):1521-5.

PMID:
21617205
[PubMed - indexed for MEDLINE]
17.

The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.

Guo R, Li LL, Zhao WH, Chen YX, Wang XZ, Fang CJ, Feng W, Zhang TL, Ma X, Lu M, Peng SQ, Yan CH.

Nanoscale. 2012 Jun 7;4(11):3577-83. doi: 10.1039/c2nr30425b. Epub 2012 Apr 30.

PMID:
22543578
[PubMed - indexed for MEDLINE]
18.

Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells.

Shmeeda H, Amitay Y, Gorin J, Tzemach D, Mak L, Ogorka J, Kumar S, Zhang JA, Gabizon A.

J Control Release. 2010 Aug 17;146(1):76-83. doi: 10.1016/j.jconrel.2010.04.028. Epub 2010 May 10.

PMID:
20462513
[PubMed - indexed for MEDLINE]
19.

Folate based radiopharmaceuticals for imaging and therapy of cancer and inflammation.

Muller C.

Curr Pharm Des. 2012;18(8):1058-83. Review.

PMID:
22272825
[PubMed - indexed for MEDLINE]
20.

Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate.

Reddy JA, Westrick E, Santhapuram HK, Howard SJ, Miller ML, Vetzel M, Vlahov I, Chari RV, Goldmacher VS, Leamon CP.

Cancer Res. 2007 Jul 1;67(13):6376-82.

PMID:
17616697
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk